Zentalis Pharmaceuticals, Inc. (ZNTL) Total liabilities 2022–2025
Zentalis Pharmaceuticals, Inc. (ZNTL) total liabilities at each fiscal year-end, per SEC filings.
$72.8MFY2025 · since FY2022: $105.3M → $72.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $72.8M | -21.9% |
| FY2024 | $93.2M | -18.5% |
| FY2023 | $114.3M | +8.6% |
| FY2022 | $105.3M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More ZNTL financial trends
ZNTL RevenueZNTL Net incomeZNTL Net marginZNTL Gross profitZNTL Gross marginZNTL Operating incomeZNTL Operating marginZNTL Operating cash flowZNTL Free cash flowZNTL Capital expendituresZNTL Return on equityZNTL Stock buybacksZNTL Dividends paidZNTL Total assetsZNTL Shareholders’ equityZNTL overview →